COMP <GO>
OFIX vs NPCE // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Orthofix Medical Inc. (NASDAQ) VS. Neuropace Inc. (NASDAQ) • 15-METRIC TALLY: OFIX 7
— NPCE 3
■ METRIC PARITY
LAST: $9.07 (-11.43%) • MKT CAP: $417.1M
options-implied-move
—
LAST: $12.30 (-5.46%) • MKT CAP: $446.6M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OFIX VS. NPCE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OFIX | NPCE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.80% | 77.20% | -8.40 | NPCE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.20% | -23.00% | +10.80 | OFIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.99% | -2.54% | +10.53 | OFIX | /fcf-yield <GO> |
| Operating Margin | -9.90% | -16.30% | +6.40 | OFIX | /operating-margins <GO> |
| Net Profit Margin | -11.20% | -21.50% | +10.30 | OFIX | /net-margins <GO> |
| Revenue Growth (YoY) | 2.90% | 25.10% | -22.20 | NPCE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.02 | 0.20 | +0.82 | OFIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | OFIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.5 | 48.7 | +8.80 | OFIX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $417.1M | $446.6M | -$29.5M | NPCE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OFIX REV | NPCE REV | OFIX GROSS % | NPCE GROSS % | OFIX FCF | NPCE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $822.3M | $100.0M | 68.8% | 77.2% | $33.3M | -$11.3M |
| FY 2024 | $799.5M | $79.9M | 68.3% | 73.9% | $25.8M | -$18.3M |
| FY 2023 | $746.6M | $65.4M | — | — | -$45.8M | -$19.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OFIX // BETA —
NPCE // BETA —